Shows
Health Trip Podcast | Jill Foos WellnessEpigenetics and Breast Cancer RiskThe two biggest breast cancer risk factors for women are being a woman and aging. In this episode, we dive into the science behind how menopause impacts breast cancer risk, explore lifestyle factors such as diet, exercise, and alcohol consumption that may contribute to breast health, and discuss the importance of regular screenings, early detection, and genetics.Whether you’re navigating perimenopause, post-menopause, or anywhere in between, our goal is to provide clear, practical information to help you manage your health with confidence. We discuss the following topics: -breast cancer risk factors ...
2022-12-0700 min
OncotargetPaper Spotlight: Remote Weight Loss Strategy for Breast Cancer SurvivorsListen to a blog summary of a trending editorial co-authored by researchers Jennifer Y. Sheng and Vered Stearns from Johns Hopkins School of Medicine and the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, entitled, "Innovating and expanding weight loss strategies for breast cancer survivors.”
___
After being diagnosed with breast cancer, up to 96% of women have reported gaining weight. Medications, inactivity, food choice, and food quantity can all lead to weight gain. Studies have shown that weight gain can increase the risk of breast cancer recurrence by 40–50% and breast cancer-related mortality by 53–60%. Thus, for women with breast cancer and those who have s...
2022-03-1006 min
Hypnotize MeHM204 Hypnosis for Hot Flashes - Does it Work?Are hot flashes taking over your life? Eek! Dr. Liz reviews two studies about hypnosis for hot flashes and lets you know if it's effective and if so, how effective! Study 1: Clinical hypnosis in the treatment of postmenopausal hot flashes: a randomized controlled trial by Gary Elkins, William Fisher, Aimee K Johnson, Janet S Carpenter, Timothy Z Keith 2013 Mar;20(3):291-8. doi: 10.1097/gme.0b013e31826ce3ed. https://journals.lww.com/menopausejournal/Abstract/2013/03000/Clinical_hypnosis_in_the_treatment_of.11.aspx Study 2: Randomized Trial of a Hypnosis Intervention for Treatment of Hot Fl...
2021-05-2812 min
Johns Hopkins Medicine A Womans Journey: Health Insights that MatterBreast Cancer AwarenessAccording to breastcancer.org, about 12% of American women will develop invasive breast cancer in their lifetime. In 2019, it's estimated that about 30% of newly diagnosed cancers in women will be breast cancer. About 85% of breast cancer diagnoses occur in women who have no family history of breast cancer. These occur due to genetic mutations that can happen as a result of the aging process, rather than inherited mutations. In the latest Insights that Matter podcast, breast cancer researcher Vered Stearns discusses new science about breast cancer.
2019-10-0129 minJohns Hopkins Medicine A Womans Journey: Health Insights that MatterBreast Cancer AwarenessAccording to breastcancer.org, about 12% of American women will develop invasive breast cancer in their lifetime. In 2019, it's estimated that about 30% of newly diagnosed cancers in women will be breast cancer. About 85% of breast cancer diagnoses occur in women who have no family history of breast cancer. These occur due to genetic mutations that can happen as a result of the aging process, rather than inherited mutations. In the latest Insights that Matter podcast, breast cancer researcher Vered Stearns discusses new science about breast cancer.
2019-10-0129 min
Frankly Speaking About Cancer with the Cancer Support CommunitySpotlight on Metastatic Breast Cancer- Clinical TrialsAll medications that are now standard treatment options went through a series of clinical trials before becoming available to patients. In this edition of our special series “Spotlight on Metastatic Breast Cancer,” we have an in-depth talk about clinical trials, their role in advancing the development of new treatments, and patient concerns about participating in them. Our guest is clinician and researcher Dr. Vered Stearns.
2019-02-051h 01
Journal of Clinical Oncology (JCO) PodcastThe End of ENDoxifen Metabolite and CYP2D6 Testing in Tamoxifen-Treated Women?This JCO Podcast provides observations and commentary on the JCO article "Tamoxifen pharmacogenetics and metabolism: Results from the prospective CYPTAM study" by Sanchez-Spitman et al. My name is Vered Stearns, and I am a Professor of Oncology and Co-Director of the Breast and Ovarian Cancer Program at the Kimmel Cancer Center at Johns Hopkins in Baltimore, Maryland. My oncologic specialty is medical oncology. In the paper that accompanies this podcast, the authors report results of a prospective clinical study designated CYPTAM, which was designed to correlate endoxifen serum concentrations and outcomes of women prescribed adjuvant tamoxifen. The investigators enrolled 667...
2019-01-2406 min